Skip to content

Monoxerutin

CARDIOVASCULAR SYSTEM

ATC C05CA02

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Monoxerutin is a drug catalogued in DrugCentral. Recorded indications include Peripheral venous insufficiency.

  • Indications: Peripheral venous insufficiency.
  • ATC code: C05CA02 (Bioflavonoids).
  • Molecular formula: C29H34O17; molecular weight 654.57 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Peripheral venous insufficiency

ATC classification

ATC codeTherapeutic hierarchy
C05CA02CARDIOVASCULAR SYSTEM › VASOPROTECTIVES › CAPILLARY STABILIZING AGENTS › Bioflavonoids

Chemical structure

Molecular formulaC29H34O17
Molecular weight654.57 g/mol
CAS number23869-24-1
InChIKeyMBHXKZDTQCSVPM-BDAFLREQSA-N
PubChem CID9852585
C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(OC4=CC(OCCO)=CC(O)=C4C3=O)C3=CC(O)=C(O)C=C3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Monoxerutin used for?

DrugCentral lists the following indications for Monoxerutin: Peripheral venous insufficiency.

What is the chemical formula of Monoxerutin?

Monoxerutin has the molecular formula C29H34O17 and a molecular weight of 654.57 g/mol.

Browse: all drugs starting with M · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets0
Indications1
FormulaC29H34O17
DrugCentral ID1835
Interactive profile